People in the News at Pacific Biosciences, Personalis, Epic Sciences, Cytek Biosciences, More
Executive appointments, promotions, and departures in omics and molecular diagnostics for the week of Oct. 31, 2022.
Epic Sciences Raises $43M in Series F Round
Epic will use the funds to further develop its multi-analyte DefineMBC liquid biopsy and expand into other business areas.
Epic Sciences, Biosplice Therapeutics Partner on Multiomic Profiling for Cancer Trials
Biosplice will use Epic's liquid biopsy platform in several clinical trials, including for its Cirtuvivint investigative drug for solid tumors.
Epic Sciences, USC Michelson Center Sign Licensing Agreement for Liquid Biopsy Research
Epic will access the center's liquid biopsy samples and expand its platform to in-depth characterization of cell-free fractions and circulating tumor cells.
Sep 10, 2020
Jan 7, 2020
Jan 2, 2019
Sep 12, 2018
Epic Sciences Raises $52M in Series E Financing
Jun 28, 2018